Track the MBX Biosciences, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3.3bn. The latest transaction was filed on 17 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Hawryluk P. Kent. The full history is accessible without an account.
39
Insider Decl.
n/a
Thresholds
€12m
8 ops.
Buy Volume
€21,132
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate MBX Biosciences, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$88.40.
49Σ signal
Buys €12m€21,132 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
MBX Biosciences, Inc. es una empresa de biotecnología centrada en el desarrollo de terapias innovadoras para enfermedades metabólicas. Cotiza en el NASDAQ bajo el ticker MBX.